# Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19

> **NCT04352985** · — · NO_LONGER_AVAILABLE · sponsor: **Spectral Diagnostics (US) Inc.**

## Conditions studied

- Septic Shock
- Endotoxemia
- COVID
- Corona Virus Infection
- Sepsis, Severe

## Interventions

- **DEVICE:** Toraymyxin PMX-20R (PMX Cartridge)

## Key facts

- **NCT ID:** NCT04352985
- **Lead sponsor:** Spectral Diagnostics (US) Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2021-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04352985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04352985, "Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04352985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*